No-Cost, No-Obligation Zantac Cancer Attorney Case Review

Antacid Cancer Attorney
Zantac Lawsuit News

Zantac Plaintiffs Could Number In The Thousands Eventually

Just one large jury award will increase media coverage and alert the public to take action

Wednesday, March 31, 2021 - The number of people that claim using Zantac caused cancer and accuse Sanofi and GalaxoSmithKline (GSK) of failing to warn them of what they knew about the drug's deadly properties could skyrocket later this year. Bellwether trials will begin later in 2021, and multi-million dollar jury awards could alert the public to seek the compensation they deserve. Cases have been organized into multidistrict litigation (MDL) and are in the very early stages of discovery and other pretrial administrative procedures. Every day the cancer death toll continues to rise. On April 1, 2020, the FDA recalled Zantac. An estimated 15 million people were taking Zantac at that time. Hundreds of thousands of plaintiffs may eventually step forward to file a cancer claim as those injured by other products have done. More than 25,000 women with ovarian cancer or mesothelioma have filed suit against Johnson & Johnson for failing to warn that Johnson's Baby Powder was contaminated with carcinogenic asbestos. More than 125,000 plaintiffs are suing Bayer for developing non-Hodgkin's lymphoma from using Monsanto's Roundup herbicide. Legal experts think that there may eventually be even more Zantac Cancer lawsuits. As is the case with other companies accused of marketing products that caused cancer, cancer has a long-term latency period. Zantac plaintiffs could be filing lawsuits for the next decade or longer.

Zantac was approved for sale by the FDA in 1983, however, no follow-up testing was performed until internet start-up prescription drug testing company Valisure came into existence. In only a couple of years, Valisure has found carcinogenic levels of NDMA in blood pressure medicines, diabetes medicines, and ranitidine used to treat heartburn and acid reflux. Plaintiffs suing Sanofi and GSK claim that they have developed many types of cancer such as stomach, bladder, esophagus, colon, breast, prostate, and others from using Zantac regularly. Most people on Zantac used the medicine up to three times per day for many years. Zantac Cancer Lawyers are interviewing former Zantac users to determine if they have the grounds to file a claim.

An additional twist in favor of plaintiffs suing Sanofi and GSK is that the Department of Justice thinks Sanofi knew years ago that ranitidine was unstable and could degrade into NDMA but withheld this information from government regulators. All the while, Sanofi made billions in profits from selling the drug. According to Reuters, on July 1, 2020, "The U.S. Department of Justice has opened an investigation into whether drugmakers including Sanofi SA failed to disclose to the federal government information about the potential presence of a probable carcinogen in the heartburn drug Zantac. Sanofi said the investigation concerns whether drugmakers violated the False Claims Act by failing to disclose to the government information about the potential presence in Zantac of N-Nitrosodimethylamine (NDMA), a probable carcinogen."

More Recent Heartburn MedicineLawsuit News:

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.